TLR5 and breast carcinoma: Further research is needed to fully elucidate the mechanisms by which TLR5 signaling can inhibit breast cancer progression and to explore the potential therapeutic applications of TLR5 agonists or antagonists in combination with other immunotherapeutic approaches.